Wird geladen...

The Many Faces of Apomorphine: Lessons from the Past and Challenges for the Future

Apomorphine is now recognized as the oldest antiparkinsonian drug on the market. Though still underused, it is increasingly prescribed in Europe for patients with advanced Parkinson’s disease (PD) with motor fluctuations. However, its history is far from being limited to movement disorders. This pap...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Drugs R D
Hauptverfasser: Auffret, Manon, Drapier, Sophie, Vérin, Marc
Format: Artigo
Sprache:Inglês
Veröffentlicht: Springer International Publishing 2018
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5995787/
https://ncbi.nlm.nih.gov/pubmed/29546602
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40268-018-0230-3
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!